Investing in iRhythm Technologies, Inc. (IRTC)  ➔  Intrinsic value

Prev. close$63.04 
ModelValueUpside
Chepakovich$19.17-70%
Graham-Dodd$4.19-93%
Graham$0.00-100%
Previous Close$63.04  
Valuation MethodValuePotential 
Chepakovich Model$19.17-70%recalculate
Graham-Dodd$4.19-93%recalculate
Graham Formula$0.00-100%recalculate

Latest news

Company description

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.